Blood & Tissue

  • Top 5 Clinical Trends in Pharma and Biologics in 2018

    Top 5 Clinical Trends in Pharma and Biologics in 2018

    More
  • ARUP Laboratories

    ARUP Laboratories

    Efficiency keeps ARUP Laboratories an industry leader.

    More
  • Top 8 Obstacles in Pharma & Biologics Product Registration & Submission Management

    Top 8 Obstacles in Pharma & Biologics Product Registration & Submission Management

    Automation can help pharmaceutical and biologics companies along the path to a global product launch. This white paper identifies common problems with submissions and how best to address them.

    More
  • Software Automation in the Blood and Biologics Industry

    Software Automation in the Blood and Biologics Industry

    This white paper explores the range of software solutions targeting organizations in the blood and biologics industry, from EDMS to QMS. Evaluate and select the most suitable solution for them.

    More
  • Compliance with FDA's Good Tissue Practices

    Compliance with FDA's Good Tissue Practices

    This Q&A breaks down the key requirements of 21 CFR Part 1270 (Human Tissue Intended for Transplantation) and Part 1271 (Human Cells, Tissues, and Cellular Tissue-Based Products).

    More
  • MasterControl Registrations™ Toolkit for Pharma & Biologics Companies

    MasterControl Registrations™ Toolkit for Pharma & Biologics Companies

    MasterControl Registrations for eCTD is a cloud-based solution designed to streamline content generation and the collection and management of artifacts required for regulatory submission.

    More
  • Common Reasons for FDA 483 Inspectional Observations in Biologics Manufacturing Environments

    Common Reasons for FDA 483 Inspectional Observations in Biologics Manufacturing Environments

    Learn about the most common 483 observations and audit findings, and avoid warning letters by staying compliant and addressing issues in the stipulated time period.

    More
  • loading
    Loading More...